Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Tilray to Acquire HEXO for $US 250 Million

Published 2023-04-10, 04:12 p/m
Updated 2023-04-10, 04:13 p/m
© Reuters.

By Ketki Saxena 

Investing.com – Cannabis company Tilray (TSX:TLRY) has announced a deal to acquire its rival Canadian cannabis company HEXO corp for $US 250 million.

Under the terms of the Arrangement Agreement, HEXO Shareholders will receive 0.4352 of a share of a Tilray share in exchange for each HEXO Share held.  The agreement implies a purchase price of US$1.25 per HEXO Share based on the volume weighted average price of Tilray Shares on the Nasdaq for the 60-day period ended on April 5, 2023. 

Warrants and other convertible securities of HEXO will also be adjusted in accordance with terms after adjustments to reflect the Arrangement and account for the Exchange Ratio.

The closing of the deal is subject to a number of conditions  including approval of at least 66⅔% of votes cast by the HEXO Shareholders at a special meeting of HEXO Shareholders, expected to take place before June 22, 2023. 

Sources report that the company’s biggest shareholders have already signed off on the deal and it is likely to be quickly approved.

If approved at the Meeting, the Arrangement is expected to close shortly thereafter, subject to regulatory approvals, approval of the court and other customary closing conditions.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.